AnaptysBio Stock (NASDAQ: ANAB) stock price, news, charts, stock research, profile.
Open | $38.67 |
Close | $35.57 |
Volume / Avg. | 226.67K / 334.38K |
Day Range | $35.55 - $38.67 |
52 Wk Range | 13.36 - 41.31 |
Market Cap | $1.07B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 25.54% |
Days to Cover | 18.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AnaptysBio (NASDAQ:ANAB) through any online brokerage.
Other companies in AnaptysBio’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Immatics (NASDAQ:IMTX).
AnaptysBio has a consensus price target of $47.64.
The stock price for AnaptysBio (NASDAQ: ANAB) is $35.57 last updated September 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for AnaptysBio.
AnaptysBio’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for AnaptysBio.
AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.